{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T05:58:11Z","timestamp":1793771891699,"version":"4.6.1"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,4,9]],"date-time":"2018-04-09T00:00:00Z","timestamp":1523232000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,4,9]],"date-time":"2018-04-09T00:00:00Z","timestamp":1523232000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>A positive surgical margin (PSM) following cancer resection oftentimes necessitates adjuvant treatments and carries significant financial and prognostic implications. We sought to compare PSM rates for the ten most common solid cancers in the United States, and to assess trends over time. Over 10 million patients were identified in the National Cancer Data Base from 1998\u20132012, and 6.5 million had surgical margin data. PSM rates were compared between two time periods, 1998\u20132002 and 2008\u20132012. PSM was positively correlated with tumor category and grade. Ovarian and prostate cancers had the highest PSM prevalence in women and men, respectively. The highest PSM rates for cancers affecting both genders were seen for oral cavity tumors. PSM rates for breast cancer and lung and bronchus cancer in both men and women declined over the study period. PSM increases were seen for bladder, colon and rectum, and kidney and renal pelvis cancers. This large-scale analysis appraises the magnitude of PSM in the United States in order to focus future efforts on improving oncologic surgical care with the goal of optimizing value and improving patient outcomes.<\/jats:p>","DOI":"10.1038\/s41598-018-23403-5","type":"journal-article","created":{"date-parts":[[2018,4,4]],"date-time":"2018-04-04T03:21:32Z","timestamp":1522812092000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":262,"title":["Positive Surgical Margins in the 10 Most Common Solid Cancers"],"prefix":"10.1038","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7885-4327","authenticated-orcid":false,"given":"Ryan K.","family":"Orosco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viridiana J.","family":"Tapia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph A.","family":"Califano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan","family":"Clary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ezra E. W.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Kane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott M.","family":"Lippman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Messer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo","family":"Molinolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James D.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Assuntina","family":"Sacco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn R.","family":"Tringale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Wallace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quyen T.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,4,9]]},"reference":[{"key":"23403_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21332","volume":"66","author":"RL Siegel","year":"2016","unstructured":"Siegel, R. L., Miller, K. D. & Jemal, A. Cancer statistics, 2016. CA Cancer J Clin 66, 7\u201330, https:\/\/doi.org\/10.3322\/caac.21332 (2016).","journal-title":"CA Cancer J Clin"},{"key":"23403_CR2","unstructured":"National Comprehensive Cancer Network. Clinical Practice Guidelines in Oncology. Version 2.2016, https:\/\/www.nccn.org\/professionals\/physician_gls\/f_guidelines.asp-site (2016)."},{"key":"23403_CR3","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3322\/caac.20138","volume":"62","author":"R Siegel","year":"2012","unstructured":"Siegel, R., Naishadham, D. & Jemal, A. Cancer statistics, 2012. CA Cancer J Clin 62, 10\u201329, https:\/\/doi.org\/10.3322\/caac.20138 (2012).","journal-title":"CA Cancer J Clin"},{"key":"23403_CR4","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/0895-4356(92)90133-8","volume":"45","author":"RA Deyo","year":"1992","unstructured":"Deyo, R. A., Cherkin, D. C. & Ciol, M. A. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 45, 613\u2013619 (1992).","journal-title":"J Clin Epidemiol"},{"key":"23403_CR5","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1001\/jama.2012.43","volume":"307","author":"LE McCahill","year":"2012","unstructured":"McCahill, L. E. et al. Variability in reexcision following breast conservation surgery. JAMA 307, 467\u2013475, https:\/\/doi.org\/10.1001\/jama.2012.43 (2012).","journal-title":"JAMA"},{"key":"23403_CR6","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1002\/cncr.11222","volume":"97","author":"F Meric","year":"2003","unstructured":"Meric, F. et al. Positive surgical margins and ipsilateral breast tumor recurrence predict disease-specific survival after breast-conserving therapy. Cancer 97, 926\u2013933, https:\/\/doi.org\/10.1002\/cncr.11222 (2003).","journal-title":"Cancer"},{"key":"23403_CR7","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/j.ijrobp.2013.11.012","volume":"88","author":"MS Moran","year":"2014","unstructured":"Moran, M. S. et al. Society of Surgical Oncology-American Society for Radiation Oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in stages I and II invasive breast cancer. Int J Radiat Oncol Biol Phys 88, 553\u2013564, https:\/\/doi.org\/10.1016\/j.ijrobp.2013.11.012 (2014).","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"23403_CR8","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1001\/jama.2009.1450","volume":"302","author":"M Morrow","year":"2009","unstructured":"Morrow, M. et al. Surgeon recommendations and receipt of mastectomy for treatment of breast cancer. JAMA 302, 1551\u20131556, https:\/\/doi.org\/10.1001\/jama.2009.1450 (2009).","journal-title":"JAMA"},{"key":"23403_CR9","doi-asserted-by":"publisher","first-page":"2158","DOI":"10.1200\/JCO.2010.29.4041","volume":"29","author":"TA King","year":"2011","unstructured":"King, T. A. et al. Clinical management factors contribute to the decision for contralateral prophylactic mastectomy. J Clin Oncol 29, 2158\u20132164, https:\/\/doi.org\/10.1200\/JCO.2010.29.4041 (2011).","journal-title":"J Clin Oncol"},{"key":"23403_CR10","doi-asserted-by":"publisher","unstructured":"Smith, B. D. et al. Cost and Complications of Local Therapies for Early-Stage Breast Cancer. J Natl Cancer Inst 109 https:\/\/doi.org\/10.1093\/jnci\/djw178 (2017).","DOI":"10.1093\/jnci\/djw178"},{"key":"23403_CR11","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1200\/JOP.2015.005694","volume":"11","author":"AJ Paravati","year":"2015","unstructured":"Paravati, A. J. et al. Variation in the Cost of Radiation Therapy Among Medicare Patients With Cancer. J Oncol Pract 11, 403\u2013409, https:\/\/doi.org\/10.1200\/JOP.2015.005694 (2015).","journal-title":"J Oncol Pract"},{"key":"23403_CR12","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1177\/0194599814551718","volume":"151","author":"AL Luryi","year":"2014","unstructured":"Luryi, A. L. et al. Positive surgical margins in early stage oral cavity cancer: an analysis of 20,602 cases. Otolaryngol Head Neck Surg 151, 984\u2013990, https:\/\/doi.org\/10.1177\/0194599814551718 (2014).","journal-title":"Otolaryngol Head Neck Surg"},{"key":"23403_CR13","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1016\/j.oraloncology.2006.10.001","volume":"43","author":"A Binahmed","year":"2007","unstructured":"Binahmed, A., Nason, R. W. & Abdoh, A. A. The clinical significance of the positive surgical margin in oral cancer. Oral Oncol 43, 780\u2013784, https:\/\/doi.org\/10.1016\/j.oraloncology.2006.10.001 (2007).","journal-title":"Oral Oncol"},{"key":"23403_CR14","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/0360-3016(87)90095-2","volume":"13","author":"TY Chen","year":"1987","unstructured":"Chen, T. Y., Emrich, L. J. & Driscoll, D. L. The clinical significance of pathological findings in surgically resected margins of the primary tumor in head and neck carcinoma. Int J Radiat Oncol Biol Phys 13, 833\u2013837 (1987).","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"23403_CR15","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1288\/00005537-199301000-00012","volume":"103","author":"JR Jacobs","year":"1993","unstructured":"Jacobs, J. R. et al. Implications of positive surgical margins. Laryngoscope 103, 64\u201368, https:\/\/doi.org\/10.1288\/00005537-199301000-00012 (1993).","journal-title":"Laryngoscope"},{"key":"23403_CR16","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/0964-1955(94)90044-2","volume":"30B","author":"AS Jones","year":"1994","unstructured":"Jones, A. S. Prognosis in mouth cancer: tumour factors. Eur J Cancer B Oral Oncol 30B, 8\u201315 (1994).","journal-title":"Eur J Cancer B Oral Oncol"},{"key":"23403_CR17","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1054\/ijom.2002.0313","volume":"32","author":"DN Sutton","year":"2003","unstructured":"Sutton, D. N., Brown, J. S., Rogers, S. N., Vaughan, E. D. & Woolgar, J. A. The prognostic implications of the surgical margin in oral squamous cell carcinoma. Int J Oral Maxillofac Surg 32, 30\u201334, https:\/\/doi.org\/10.1054\/ijom.2002.0313 (2003).","journal-title":"Int J Oral Maxillofac Surg"},{"key":"23403_CR18","doi-asserted-by":"publisher","unstructured":"Acevedo, J. R. et al. Cost-Effectiveness Analysis of Elective Neck Dissection in Patients With Clinically Node-Negative Oral Cavity Cancer. J Clin Oncol https:\/\/doi.org\/10.1200\/JCO.2016.68.4563 (2016).","DOI":"10.1200\/JCO.2016.68.4563"},{"key":"23403_CR19","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.eururo.2010.03.007","volume":"58","author":"RT Divrik","year":"2010","unstructured":"Divrik, R. T., Sahin, A. F., Yildirim, U., Altok, M. & Zorlu, F. Impact of routine second transurethral resection on the long-term outcome of patients with newly diagnosed pT1 urothelial carcinoma with respect to recurrence, progression rate, and disease-specific survival: a prospective randomised clinical trial. Eur Urol 58, 185\u2013190, https:\/\/doi.org\/10.1016\/j.eururo.2010.03.007 (2010).","journal-title":"Eur Urol"},{"key":"23403_CR20","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.juro.2010.03.037","volume":"184","author":"NJ Hellenthal","year":"2010","unstructured":"Hellenthal, N. J. et al. Surgical margin status after robot assisted radical cystectomy: results from the International Robotic Cystectomy Consortium. J Urol 184, 87\u201391, https:\/\/doi.org\/10.1016\/j.juro.2010.03.037 (2010).","journal-title":"J Urol"},{"key":"23403_CR21","doi-asserted-by":"publisher","unstructured":"Dotan, Z. A. et al. Positive surgical margins in soft tissue following radical cystectomy for bladder cancer and cancer specific survival. J Urol 178, 2308\u20132312; discussion 2313 https:\/\/doi.org\/10.1016\/j.juro.2007.08.023 (2007).","DOI":"10.1016\/j.juro.2007.08.023"},{"key":"23403_CR22","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1016\/j.urolonc.2014.05.001","volume":"32","author":"SM Stevenson","year":"2014","unstructured":"Stevenson, S. M. et al. Cost-effectiveness of neoadjuvant chemotherapy before radical cystectomy for muscle-invasive bladder cancer. Urol Oncol 32, 1172\u20131177, https:\/\/doi.org\/10.1016\/j.urolonc.2014.05.001 (2014).","journal-title":"Urol Oncol"},{"key":"23403_CR23","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.amjsurg.2016.11.038","volume":"213","author":"A Kanters","year":"2017","unstructured":"Kanters, A. et al. Colorectal cancer: Quality of surgical care in Michigan. Am J Surg 213, 548\u2013552, https:\/\/doi.org\/10.1016\/j.amjsurg.2016.11.038 (2017).","journal-title":"Am J Surg"},{"key":"23403_CR24","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1016\/j.surg.2016.05.028","volume":"160","author":"QD Chu","year":"2016","unstructured":"Chu, Q. D., Zhou, M., Medeiros, K. & Peddi, P. Positive surgical margins contribute to the survival paradox between patients with stage IIB\/C (T4N0) and stage IIIA (T1-2N1, T1N2a) colon cancer. Surgery 160, 1333\u20131343, https:\/\/doi.org\/10.1016\/j.surg.2016.05.028 (2016).","journal-title":"Surgery"},{"key":"23403_CR25","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1097\/01.sla.0000257358.56863.ce","volume":"246","author":"KC Peeters","year":"2007","unstructured":"Peeters, K. C. et al. The TME trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma. Ann Surg 246, 693\u2013701, https:\/\/doi.org\/10.1097\/01.sla.0000257358.56863.ce (2007).","journal-title":"Ann Surg"},{"key":"23403_CR26","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.amjsurg.2013.03.009","volume":"206","author":"HH Lin","year":"2013","unstructured":"Lin, H. H. et al. Circumferential margin plays an independent impact on the outcome of rectal cancer patients receiving curative total mesorectal excision. Am J Surg 206, 771\u2013777, https:\/\/doi.org\/10.1016\/j.amjsurg.2013.03.009 (2013).","journal-title":"Am J Surg"},{"key":"23403_CR27","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1097\/DCR.0000000000000737","volume":"60","author":"A Sasikumar","year":"2017","unstructured":"Sasikumar, A., Bhan, C., Jenkins, J. T., Antoniou, A. & Murphy, J. Systematic Review of Pelvic Exenteration With En Bloc Sacrectomy for Recurrent Rectal Adenocarcinoma: R0 Resection Predicts Disease-free Survival. Dis Colon Rectum 60, 346\u2013352, https:\/\/doi.org\/10.1097\/DCR.0000000000000737 (2017).","journal-title":"Dis Colon Rectum"},{"key":"23403_CR28","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1056\/NEJMp048143","volume":"351","author":"D Schrag","year":"2004","unstructured":"Schrag, D. The price tag on progress\u2013chemotherapy for colorectal cancer. N Engl J Med 351, 317\u2013319, https:\/\/doi.org\/10.1056\/NEJMp048143 (2004).","journal-title":"N Engl J Med"},{"key":"23403_CR29","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.clgc.2012.09.010","volume":"11","author":"M Borghesi","year":"2013","unstructured":"Borghesi, M., Brunocilla, E., Schiavina, R. & Martorana, G. Positive surgical margins after nephron-sparing surgery for renal cell carcinoma: incidence, clinical impact, and management. Clin Genitourin Cancer 11, 5\u20139, https:\/\/doi.org\/10.1016\/j.clgc.2012.09.010 (2013).","journal-title":"Clin Genitourin Cancer"},{"key":"23403_CR30","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/j.eururo.2011.11.028","volume":"61","author":"M Marszalek","year":"2012","unstructured":"Marszalek, M. et al. Positive surgical margins after nephron-sparing surgery. Eur Urol 61, 757\u2013763, https:\/\/doi.org\/10.1016\/j.eururo.2011.11.028 (2012).","journal-title":"Eur Urol"},{"key":"23403_CR31","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s00345-010-0576-9","volume":"29","author":"DJ Lee","year":"2011","unstructured":"Lee, D. J., Hruby, G., Benson, M. C. & McKiernan, J. M. Renal function and oncologic outcomes in nephron sparing surgery for renal masses in solitary kidneys. World J Urol 29, 343\u2013348, https:\/\/doi.org\/10.1007\/s00345-010-0576-9 (2011).","journal-title":"World J Urol"},{"key":"23403_CR32","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.urology.2009.06.110","volume":"75","author":"O Raz","year":"2010","unstructured":"Raz, O. et al. Positive surgical margins with renal cell carcinoma have a limited influence on long-term oncological outcomes of nephron sparing surgery. Urology 75, 277\u2013280, https:\/\/doi.org\/10.1016\/j.urology.2009.06.110 (2010).","journal-title":"Urology"},{"key":"23403_CR33","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1016\/j.juro.2013.05.110","volume":"190","author":"A Khalifeh","year":"2013","unstructured":"Khalifeh, A. et al. Positive surgical margins in robot-assisted partial nephrectomy: a multi-institutional analysis of oncologic outcomes (leave no tumor behind). J Urol 190, 1674\u20131679, https:\/\/doi.org\/10.1016\/j.juro.2013.05.110 (2013).","journal-title":"J Urol"},{"key":"23403_CR34","doi-asserted-by":"publisher","unstructured":"Little, A. G. et al. Patterns of surgical care of lung cancer patients. Ann Thorac Surg 80, 2051\u20132056 discussion 2056 https:\/\/doi.org\/10.1016\/j.athoracsur.2005.06.071 (2005).","DOI":"10.1016\/j.athoracsur.2005.06.071"},{"key":"23403_CR35","doi-asserted-by":"publisher","unstructured":"Osarogiagbon, R. U. et al. Prognostic Value of National Comprehensive Cancer Network Lung Cancer Resection Quality Criteria. Ann Thorac Surg https:\/\/doi.org\/10.1016\/j.athoracsur.2017.01.098 (2017).","DOI":"10.1016\/j.athoracsur.2017.01.098"},{"key":"23403_CR36","doi-asserted-by":"publisher","first-page":"113","DOI":"10.3389\/fonc.2015.00113","volume":"5","author":"A Thomas","year":"2015","unstructured":"Thomas, A., Chen, Y., Yu, T., Jakopovic, M. & Giaccone, G. Trends and Characteristics of Young Non-Small Cell Lung Cancer Patients in the United States. Front Oncol 5, 113, https:\/\/doi.org\/10.3389\/fonc.2015.00113 (2015).","journal-title":"Front Oncol"},{"key":"23403_CR37","doi-asserted-by":"publisher","first-page":"424","DOI":"10.3978\/j.issn.2218-6751.2015.08.01","volume":"4","author":"RU Osarogiagbon","year":"2015","unstructured":"Osarogiagbon, R. U. & D\u2019Amico, T. A. Improving lung cancer outcomes by improving the quality of surgical care. Transl Lung Cancer Res 4, 424\u2013431, https:\/\/doi.org\/10.3978\/j.issn.2218-6751.2015.08.01 (2015).","journal-title":"Transl Lung Cancer Res"},{"key":"23403_CR38","doi-asserted-by":"publisher","first-page":"242","DOI":"10.3978\/j.issn.2218-6751.2013.12.05","volume":"3","author":"H Uramoto","year":"2014","unstructured":"Uramoto, H. & Tanaka, F. Recurrence after surgery in patients with NSCLC. Transl Lung Cancer Res 3, 242\u2013249, https:\/\/doi.org\/10.3978\/j.issn.2218-6751.2013.12.05 (2014).","journal-title":"Transl Lung Cancer Res"},{"key":"23403_CR39","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.lungcan.2006.10.017","volume":"55","author":"J Pfannschmidt","year":"2007","unstructured":"Pfannschmidt, J., Muley, T., Bulzebruck, H., Hoffmann, H. & Dienemann, H. Prognostic assessment after surgical resection for non-small cell lung cancer: experiences in 2083 patients. Lung Cancer 55, 371\u2013377, https:\/\/doi.org\/10.1016\/j.lungcan.2006.10.017 (2007).","journal-title":"Lung Cancer"},{"key":"23403_CR40","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1056\/NEJMoa031644","volume":"350","author":"R Arriagada","year":"2004","unstructured":"Arriagada, R. et al. Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer. N Engl J Med 350, 351\u2013360, https:\/\/doi.org\/10.1056\/NEJMoa031644 (2004).","journal-title":"N Engl J Med"},{"key":"23403_CR41","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1016\/j.athoracsur.2009.11.052","volume":"89","author":"M Riquet","year":"2010","unstructured":"Riquet, M. et al. Microscopic residual disease after resection for lung cancer: a multifaceted but poor factor of prognosis. Ann Thorac Surg 89, 870\u2013875, https:\/\/doi.org\/10.1016\/j.athoracsur.2009.11.052 (2010).","journal-title":"Ann Thorac Surg"},{"key":"23403_CR42","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.ejcts.2007.04.003","volume":"32","author":"J Wind","year":"2007","unstructured":"Wind, J., Smit, E. J., Senan, S. & Eerenberg, J. P. Residual disease at the bronchial stump after curative resection for lung cancer. Eur J Cardiothorac Surg 32, 29\u201334, https:\/\/doi.org\/10.1016\/j.ejcts.2007.04.003 (2007).","journal-title":"Eur J Cardiothorac Surg"},{"key":"23403_CR43","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1002\/jso.24130","volume":"113","author":"JD Predina","year":"2016","unstructured":"Predina, J. D., Keating, J., Patel, N., Nims, S. & Singhal, S. Clinical implications of positive margins following non-small cell lung cancer surgery. J Surg Oncol 113, 264\u2013269, https:\/\/doi.org\/10.1002\/jso.24130 (2016).","journal-title":"J Surg Oncol"},{"key":"23403_CR44","doi-asserted-by":"publisher","first-page":"733","DOI":"10.2174\/1389201014666131226113300","volume":"14","author":"H Orbay","year":"2013","unstructured":"Orbay, H., Bean, J., Zhang, Y. & Cai, W. Intraoperative targeted optical imaging: a guide towards tumor-free margins in cancer surgery. Curr Pharm Biotechnol 14, 733\u2013742 (2013).","journal-title":"Curr Pharm Biotechnol"},{"key":"23403_CR45","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.addr.2014.07.008","volume":"76","author":"L Bu","year":"2014","unstructured":"Bu, L., Shen, B. & Cheng, Z. Fluorescent imaging of cancerous tissues for targeted surgery. Adv Drug Deliv Rev 76, 21\u201338, https:\/\/doi.org\/10.1016\/j.addr.2014.07.008 (2014).","journal-title":"Adv Drug Deliv Rev"},{"key":"23403_CR46","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.lungcan.2008.11.020","volume":"65","author":"T Woo","year":"2009","unstructured":"Woo, T. et al. Prognostic value of KRAS mutations and Ki-67 expression in stage I lung adenocarcinomas. Lung Cancer 65, 355\u2013362, https:\/\/doi.org\/10.1016\/j.lungcan.2008.11.020 (2009).","journal-title":"Lung Cancer"},{"key":"23403_CR47","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1089\/thy.2015.0141","volume":"25","author":"LY Wang","year":"2015","unstructured":"Wang, L. Y. et al. Microscopic Positive Margins in Differentiated Thyroid Cancer Is Not an Independent Predictor of Local Failure. Thyroid 25, 993\u2013998, https:\/\/doi.org\/10.1089\/thy.2015.0141 (2015).","journal-title":"Thyroid"},{"key":"23403_CR48","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.2217\/fon.10.127","volume":"6","author":"R Rahbari","year":"2010","unstructured":"Rahbari, R., Zhang, L. & Kebebew, E. Thyroid cancer gender disparity. Future Oncol 6, 1771\u20131779, https:\/\/doi.org\/10.2217\/fon.10.127 (2010).","journal-title":"Future Oncol"},{"key":"23403_CR49","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1002\/hed.23406","volume":"36","author":"DM Hartl","year":"2014","unstructured":"Hartl, D. M. et al. Resection margins and prognosis in locally invasive thyroid cancer. Head Neck 36, 1034\u20131038, https:\/\/doi.org\/10.1002\/hed.23406 (2014).","journal-title":"Head Neck"},{"key":"23403_CR50","doi-asserted-by":"publisher","unstructured":"Bilimoria, K. Y. et al. Extent of surgery affects survival for papillary thyroid cancer. Ann Surg 246, 375\u2013381 discussion 381-374 https:\/\/doi.org\/10.1097\/SLA.0b013e31814697d9 (2007).","DOI":"10.1097\/SLA.0b013e31814697d9"},{"key":"23403_CR51","doi-asserted-by":"publisher","unstructured":"Adam, M. A. et al. Extent of surgery for papillary thyroid cancer is not associated with survival: an analysis of 61,775 patients. Ann Surg 260, 601\u2013605 discussion 605\u2013607 https:\/\/doi.org\/10.1097\/SLA.0000000000000925 (2014).","DOI":"10.1097\/SLA.0000000000000925"},{"key":"23403_CR52","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/s12149-012-0574-7","volume":"26","author":"CM Hong","year":"2012","unstructured":"Hong, C. M. et al. Prognostic implications of microscopic involvement of surgical resection margin in patients with differentiated papillary thyroid cancer after high-dose radioactive iodine ablation. Ann Nucl Med 26, 311\u2013318, https:\/\/doi.org\/10.1007\/s12149-012-0574-7 (2012).","journal-title":"Ann Nucl Med"},{"key":"23403_CR53","doi-asserted-by":"publisher","unstructured":"American Thyroid Association Guidelines Taskforce on Thyroid, N. et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 19, 1167\u20131214, https:\/\/doi.org\/10.1089\/thy.2009.0110 (2009).","DOI":"10.1089\/thy.2009.0110"},{"key":"23403_CR54","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/S0002-9610(99)80331-6","volume":"170","author":"PE Andersen","year":"1995","unstructured":"Andersen, P. E., Kinsella, J., Loree, T. R., Shaha, A. R. & Shah, J. P. Differentiated carcinoma of the thyroid with extrathyroidal extension. Am J Surg 170, 467\u2013470 (1995).","journal-title":"Am J Surg"},{"key":"23403_CR55","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/S0002-9610(05)80326-5","volume":"166","author":"JP Shah","year":"1993","unstructured":"Shah, J. P., Loree, T. R., Dharker, D. & Strong, E. W. Lobectomy versus total thyroidectomy for differentiated carcinoma of the thyroid: a matched-pair analysis. Am J Surg 166, 331\u2013335 (1993).","journal-title":"Am J Surg"},{"key":"23403_CR56","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.clon.2010.05.004","volume":"22","author":"JA Sipos","year":"2010","unstructured":"Sipos, J. A. & Mazzaferri, E. L. Thyroid cancer epidemiology and prognostic variables. Clin Oncol (R Coll Radiol) 22, 395\u2013404, https:\/\/doi.org\/10.1016\/j.clon.2010.05.004 (2010).","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"23403_CR57","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1177\/0194599814521583","volume":"150","author":"M Marino","year":"2014","unstructured":"Marino, M. et al. Costs of outpatient thyroid surgery from the University HealthSystem Consortium (UHC) database. Otolaryngol Head Neck Surg 150, 762\u2013769, https:\/\/doi.org\/10.1177\/0194599814521583 (2014).","journal-title":"Otolaryngol Head Neck Surg"},{"key":"23403_CR58","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.urolonc.2009.09.019","volume":"28","author":"MS Cookson","year":"2010","unstructured":"Cookson, M. S. & Chang, S. S. Margin control in open radical prostatectomy: what are the real outcomes? Urol Oncol 28, 205\u2013209, https:\/\/doi.org\/10.1016\/j.urolonc.2009.09.019 (2010).","journal-title":"Urol Oncol"},{"key":"23403_CR59","doi-asserted-by":"publisher","first-page":"423","DOI":"10.4103\/0970-1591.134240","volume":"30","author":"JL Silberstein","year":"2014","unstructured":"Silberstein, J. L. & Eastham, J. A. Significance and management of positive surgical margins at the time of radical prostatectomy. Indian J Urol 30, 423\u2013428, https:\/\/doi.org\/10.4103\/0970-1591.134240 (2014).","journal-title":"Indian J Urol"},{"key":"23403_CR60","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.eururo.2013.07.039","volume":"65","author":"O Yossepowitch","year":"2014","unstructured":"Yossepowitch, O. et al. Positive surgical margins after radical prostatectomy: a systematic review and contemporary update. Eur Urol 65, 303\u2013313, https:\/\/doi.org\/10.1016\/j.eururo.2013.07.039 (2014).","journal-title":"Eur Urol"},{"issue":"18","key":"23403_CR61","doi-asserted-by":"publisher","first-page":"e11","DOI":"10.1016\/j.urolonc.2014.09.006","volume":"33","author":"MA Preston","year":"2015","unstructured":"Preston, M. A. et al. The association between nerve sparing and a positive surgical margin during radical prostatectomy. Urol Oncol 33(18), e11\u201316, https:\/\/doi.org\/10.1016\/j.urolonc.2014.09.006 (2015).","journal-title":"Urol Oncol"},{"key":"23403_CR62","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.eururo.2012.05.047","volume":"62","author":"G Novara","year":"2012","unstructured":"Novara, G. et al. Systematic review and meta-analysis of studies reporting oncologic outcome after robot-assisted radical prostatectomy. Eur Urol 62, 382\u2013404, https:\/\/doi.org\/10.1016\/j.eururo.2012.05.047 (2012).","journal-title":"Eur Urol"},{"key":"23403_CR63","doi-asserted-by":"publisher","first-page":"2213","DOI":"10.1016\/j.juro.2010.02.017","volume":"183","author":"JL Wright","year":"2010","unstructured":"Wright, J. L. et al. Positive surgical margins at radical prostatectomy predict prostate cancer specific mortality. J Urol 183, 2213\u20132218, https:\/\/doi.org\/10.1016\/j.juro.2010.02.017 (2010).","journal-title":"J Urol"},{"key":"23403_CR64","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.eururo.2012.08.002","volume":"64","author":"J Mauermann","year":"2013","unstructured":"Mauermann, J. et al. The impact of solitary and multiple positive surgical margins on hard clinical end points in 1712 adjuvant treatment-naive pT2-4 N0 radical prostatectomy patients. Eur Urol 64, 19\u201325, https:\/\/doi.org\/10.1016\/j.eururo.2012.08.002 (2013).","journal-title":"Eur Urol"},{"key":"23403_CR65","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2490-14-86","volume":"14","author":"VP Retel","year":"2014","unstructured":"Retel, V. P. et al. Determinants and effects of positive surgical margins after prostatectomy on prostate cancer mortality: a population-based study. BMC Urol 14, 86, https:\/\/doi.org\/10.1186\/1471-2490-14-86 (2014).","journal-title":"BMC Urol"},{"key":"23403_CR66","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1377\/hlthaff.2011.1062","volume":"31","author":"BL Jacobs","year":"2012","unstructured":"Jacobs, B. L., Zhang, Y., Skolarus, T. A. & Hollenbeck, B. K. Growth of high-cost intensity-modulated radiotherapy for prostate cancer raises concerns about overuse. Health Aff (Millwood) 31, 750\u2013759, https:\/\/doi.org\/10.1377\/hlthaff.2011.1062 (2012).","journal-title":"Health Aff (Millwood)"},{"key":"23403_CR67","first-page":"111","volume":"3","author":"JO Schorge","year":"2010","unstructured":"Schorge, J. O., McCann, C. & Del Carmen, M. G. Surgical debulking of ovarian cancer: what difference does it make? Rev Obstet Gynecol 3, 111\u2013117 (2010).","journal-title":"Rev Obstet Gynecol"},{"key":"23403_CR68","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1200\/JCO.2002.20.5.1248","volume":"20","author":"RE Bristow","year":"2002","unstructured":"Bristow, R. E., Tomacruz, R. S., Armstrong, D. K., Trimble, E. L. & Montz, F. J. Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis. J Clin Oncol 20, 1248\u20131259, https:\/\/doi.org\/10.1200\/JCO.2002.20.5.1248 (2002).","journal-title":"J Clin Oncol"},{"key":"23403_CR69","doi-asserted-by":"crossref","unstructured":"Hoskins, W. J. et al. The effect of diameter of largest residual disease on survival after primary cytoreductive surgery in patients with suboptimal residual epithelial ovarian carcinoma. Am J Obstet Gynecol 170, 974\u2013979 discussion 979-980 (1994).","DOI":"10.1016\/S0002-9378(94)70090-7"},{"key":"23403_CR70","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.ygyno.2006.03.051","volume":"103","author":"DS Chi","year":"2006","unstructured":"Chi, D. S. et al. What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC)? Gynecol Oncol 103, 559\u2013564, https:\/\/doi.org\/10.1016\/j.ygyno.2006.03.051 (2006).","journal-title":"Gynecol Oncol"},{"key":"23403_CR71","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1200\/JCO.2007.13.1953","volume":"26","author":"WE Winter 3rd","year":"2008","unstructured":"Winter, W. E. 3rd et al. Tumor residual after surgical cytoreduction in prediction of clinical outcome in stage IV epithelial ovarian cancer: a Gynecologic Oncology Group Study. J Clin Oncol 26, 83\u201389, https:\/\/doi.org\/10.1200\/JCO.2007.13.1953 (2008).","journal-title":"J Clin Oncol"},{"issue":"Suppl 1","key":"23403_CR72","doi-asserted-by":"publisher","first-page":"S105","DOI":"10.1016\/S0020-7292(06)60031-3","volume":"95","author":"WT Creasman","year":"2006","unstructured":"Creasman, W. T. et al. Carcinoma of the corpus uteri. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet 95(Suppl 1), S105\u2013143, https:\/\/doi.org\/10.1016\/S0020-7292(06)60031-3 (2006).","journal-title":"Int J Gynaecol Obstet"},{"key":"23403_CR73","doi-asserted-by":"crossref","unstructured":"Odicino, F., Tisi, G. C., Miscioscia, R. & Pasinetti, B. Controversies in the Surgery of Endometrial Cancer. In Cancer of the Uterine Endometrium-Advances and Controversies. InTech (2012).","DOI":"10.5772\/26181"},{"key":"23403_CR74","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1046\/j.1525-1438.2001.01061.x","volume":"11","author":"E Sartori","year":"2001","unstructured":"Sartori, E. et al. Clinical behavior of 203 stage II endometrial cancer cases: the impact of primary surgical approach and of adjuvant radiation therapy. Int J Gynecol Cancer 11, 430\u2013437 (2001).","journal-title":"Int J Gynecol Cancer"},{"key":"23403_CR75","first-page":"373","volume":"1","author":"A Gadducci","year":"2003","unstructured":"Gadducci, A., Cosio, S. & Genazzani, A. R. Treatment Planning in Endometrial Cancer. Cancer Therapy. 1, 373\u2013391 (2003).","journal-title":"Cancer Therapy."},{"key":"23403_CR76","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.ygyno.2016.10.018","volume":"143","author":"BL Seagle","year":"2016","unstructured":"Seagle, B. L. et al. Survival after pelvic exenteration for uterine malignancy: A National Cancer Data Base study. Gynecol Oncol 143, 472\u2013478, https:\/\/doi.org\/10.1016\/j.ygyno.2016.10.018 (2016).","journal-title":"Gynecol Oncol"},{"key":"23403_CR77","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.ygyno.2007.08.072","volume":"108","author":"JA Lachance","year":"2008","unstructured":"Lachance, J. A., Stukenborg, G. J., Schneider, B. F., Rice, L. W. & Jazaeri, A. A. A cost-effective analysis of adjuvant therapies for the treatment of stage I endometrial adenocarcinoma. Gynecol Oncol 108, 77\u201383, https:\/\/doi.org\/10.1016\/j.ygyno.2007.08.072 (2008).","journal-title":"Gynecol Oncol"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-23403-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-23403-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-23403-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T04:06:57Z","timestamp":1671595617000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-23403-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,9]]},"references-count":77,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["23403"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-23403-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,9]]},"assertion":[{"value":"6 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"5686"}}